Folic acid for the prevention of congenital anomalies

European Journal of Pediatrics

Volumn 157, Issue 6, 1998, Pages 445-450

  Hall, J ^a   Solehdin, F ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

Author keywords

5,10 Methylenetetrahydrofolate reductase; Birth defects; Folic acid; Neural tube defects; Primary prevention

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID;

CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CRANIOFACIAL MALFORMATION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DNA POLYMORPHISM; FOLIC ACID DEFICIENCY; GENE MUTATION; HUMAN; HYPERTROPHIC PYLORUS STENOSIS; INTRAUTERINE GROWTH RETARDATION; LIMB DEFECT; NEURAL TUBE DEFECT; PREMATURE LABOR; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SOLUTIO PLACENTAE; URINARY TRACT MALFORMATION;

ABNORMALITIES; ADULT; FOLIC ACID; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEURAL TUBE DEFECTS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS;

EID: 0031835515     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050850     Document Type: Review

References (49)

1. Anonymous (1993) Folic acid for the prevention of recurrent neural tube defects. ACOG Committee opinion: Committee on obstetrics: maternal fetal medicine number 120-March 1993 Int J Gynaecol Obstet 42:75-77
2. Anonymous (1996) Canada adopts US stand on folic acid additive. The Medical Post 32:19
3. Anonymous (1997) Knowledge and use of folic acid by women of childbearing age - United States, 1997. MMWR 46:721-723
4. Baird PA (1983) Neural tube defects in the Sikhs. Am J Med Genet 16:49-56
5. Baird PA, Anderson TW, Newcombe HB, Lowry RB (1988) Genetic disorders in children and young adults: a population study. Am J Hum Genet 42:677-693
6. Botto LD, Khoury MJ, Mulinare J, Erickson JD (1996) Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 98:911-917
7. Butterworth CE, Hatch KD, Soong S-J, Cole P, Tamura T, Sauberlich HE, Borst M, Macaluso M, Baker V (1992) Oral folic acid supplementation for cervical dysplasia: a clinical intervention trial. Am J Obstet Gynecol 166:803-809
8. CDC (1996) Infant mortality-United States. JAMA 275:980
9. Centers for Disease Control (1980) Congenital malformations surveillance report, January-December, 1979
10. Centers for Disease Control and Prevention (1992) Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 41(No. RR-14):1-7
11. Christianson RE, Berg BJ van den, Milkovich L, Oechsli FW (1981) Incidence of congenital anomalies among white and black live births with long-term follow-up. Am J Public Health 71:1333-1341
12. Cornel MC, Erickson JD (1997) Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly (SBA). Teratology 55:134-137
13. Czeizel AE (1996) Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 62:179-183
14. Czeizel AE, Dudas I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835
15. De Franchis R, Sebastio G, Mandato C, Andria G, Mastroiacovo P (1995) Spina bifida, 677C→T mutation, and role of folate. Lancet 346:1703
16. Elwood JH (1976) Major central nervous system malformations notified in Northern Ireland. Dev Med Child Neurol 18:512-520
17. Frecker M, Fraser FC (1987) Epidemiological studies of neural tube defects in Newfoundland. Teratology 36:355-361
18. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Mathews RG, Boers GHJ (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
19. Goddijn-Wessel TAW, Wouters MGAJ, Molen EF van der, Spuijbroek MDEH, Steegers-Theunissen RPM, Blom HJ, Boers GHJ, Eskes TKAB (1996) Hyperhomocysteinemia: is a risk factor for placental abruption or infarction. Eur J Obstet Gynecol 66:23-29
20. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, Rozen R (1994) Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 7:195-200
21. Greenberg F, James LM, Oakley GP Jr (1983) Estimates of birth prevalence rates of spina bifida in the United States from computer-generated maps. Am J Obst Gynecol 145:570-573
22. Hibbard BM, Hibbard E (1963) Aetiological factors in abruptio placentae. BMJ 2:1430-1436
23. Jacques PF, Bostom AG, Williams RR, Ellison RC. Eekfeldt JH, Rosenberg IH, Selhub J, Rozen R (1996) Relation between folate status, a common mutaion in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7-9
24. Lary JM, Edmonds LD (1996) Prevalence of spina bifida at birth United States, 1983-1990: a comparison of two surveillance systems. MMWR 45(SS-2):15-26
25. Lashner BA, Proencher KS, Seidner DL, Knesebeck A, Brzezinski A (1997) The Effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative Colitis. Gastroenterology 112:29-32
26. Li D-K, Daling JR, Mueller BA, Hickok DE, Fantel AG, Weiss NS (1995) Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 6:212-218
27. Ling EW, Sosuan LC, Hall JC (1991) Congenital anomalies: an increasingly important cause of mortality and workload in a neonatal intensive care unit. Am J Perinatol 8:164-169
28. Lynberg MC, Khoury MJ (1990) Contribution of birth defects to infant mortality among racial ethnic minority groups. United States, 1983. MMWR Surveill Summ 39(SS-3):1-12
29. Marden PM, Smith MD, McDonald MJ (1964) Congenital anomalies in the newborn infant, including minor variations. J Pediatr 64:357-371
30. Motulsky AG (1996) Nutritional ecogenetics: homocysteine related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 58:17-20
31. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131-137
32. Myrianthopoulos NG, Chung CS (1974) Congenital malformations in singletons: epidemiologic survey. In: Bergsma D (ed) Birth Defects Original Article Series. The National Foundation. March of Dimes Vol. X. No 11
33. National Health and Medical Research Council (1994) NH & MRC Statement. Revised statement on the relationship between dietary folic acid and neural tube defects, such as spina bifida. J Paediatr Child Health 30:476:477
34. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, Rozen R, Oakley GP, Adams MJ (1996) 5,10 methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 63:610-614
35. Pearce HR, Smith NA, Fox EF, Bingman JS (1996) Periconceptional folic acid: knowledge amongst patients and health care workers in a London teaching hospital. Br J Fam Plann 22:20-21
36. Scholl TO, Hediger ML, Schall JI, Khoo C-S, Fischer RL (1996) Dietary and serum folate: their influence on the outcome of pregnancy. Am J Clin Nutr 63:520-525
37. Shaw GM, Jensvold NG, Wasserman CR, Lammer EJ (1994) Epidemiolgic characteristics of phenotypically distinct neural tube defects among 0.7 million California births. 1983-1987. Teratology 49:143-149
38. Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM (1995) Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 345:393-396
39. Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ (1995) Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 59:536-545
40. Stevenson RE, Schwartz CE, Du Y-Z, Adams MJ (1997) Differences in methylenetetrahydrofolate reductase genotype frequencies, between whites and blacks. Am J Hum Genet 60:229-230
41. Stone ML (1968) Effects on the fetus of folic acid deficiency in pregnancy. Clin Obstet Gynecol 11:1143-1153
42. Tolarova M, Harris J (1995) Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology 51:71-78
43. Tucker KL, Mahnken B, Wilson PWF, Jacques P, Jacob S (1996) Folic acid fortification of the food supply. Potential benefits and risks fir the elderly population. JAMA 276:1879-1885
44. US Dept of Health and Human Services (1993) Food and Drug Administration. Food standards: amendment of the standards of identity for enriched grain products to require addition of folic acid. Federal Register 58:53306-53312
45. Van Allen MI, Fraser FC, Dallaire L, Allanson J, McLeod R, Andermann E, Friedman J (1993) Recommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects. Clinical Teratology Committee, Canadian College of Medical Geneticists. Can Med Assoc J 149:1239-1243
46. Van der Put N, Steegers-Theunissen RPM, Frosst P, Trijbels FJ, Eskes TK, Heuvel LP van den, Mariman EC, Heyer M den, Rozen R, Blom HJ (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071
47. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Sheilds DC, Scott JM (1995) A genetic-defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 88:763-766
48. Wild J, Sutcliffe M, Schorah CJ, Leven MI (1997) Prevention of neural-tube defects. Lancet 350:30-31
49. Wilson RD, Van Allen MI (1993) SOGC Genetics Committee. Recommendations on the use of folic acid for the prevention of neural tube defects. J SOGC 15:41-44